TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
$36.34-$1.18 (-3.14%) Today
Tal Zvi Zaks - DirectorTeva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 205,782 | $7.09M |
| Option exercise | 28 | 469,968 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
89 Form 4 filings on record, the earliest from Nov 21, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 891,315 | - | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 412,032 | $32.36 | $13.33M | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 67,231 | $0.00 | - | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 891,315 | $0.00 | - | |
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 67,231 | - | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 30,903 | $32.36 | $1.00M | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Ordinary Shares | 141,478 | - | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Restricted Share Units | 49,800 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Restricted Share Units | 141,478 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Ordinary Shares | 49,800 | - | - | |
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 24,900 | - | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 12,077 | $32.36 | $391K | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 141,478 | $0.00 | - | |
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 141,478 | - | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 68,685 | $32.36 | $2.22M | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 24,900 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Open-market sale | Ordinary Shares | 345,810 | $33.64 | $11.63M | |
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 161,656 | - | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 161,656 | $34.22 | $5.53M | |
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 620,110 | - | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 286,122 | $34.22 | $9.79M | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 161,656 | $0.00 | - | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 620,110 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Grant or award | Restricted Share Units | 141,478 | $0.00 | - | |
| Eric A. Hughes - Officer | Grant or award | Restricted Share Units | 141,478 | $0.00 | - | |
| Mark Sabag - Officer | Grant or award | Restricted Share Units | 141,478 | $0.00 | - | |
| Richard Daniell - Officer | Grant or award | Restricted Share Units | 141,478 | $0.00 | - | |
| Richard D. Francis - Officer | Grant or award | Restricted Share Units | 620,110 | $0.00 | - | |
| Richard D. Francis - Officer | Grant or award | Restricted Share Units | 891,315 | $0.00 | - | |
| Amir Weiss - Officer | Open-market sale | Ordinary Shares | 12,300 | $30.20 | $372K | |
| Roberto Mignone | Open-market sale | Ordinary Shares | 77,400 | $30.24 | $2.34M | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 100,457 | $18.61 | $1.87M | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 15,011 | $16.99 | $255K | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 115,468 | $28.68 | $3.31M | |
| Richard Daniell - Officer | Option exercise | Stock Options (right to buy) | 100,457 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Stock Options (right to buy) | 15,011 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 118,724 | $18.61 | $2.21M | |
| Mark Sabag - Officer | Open-market sale | Ordinary Shares | 118,724 | $28.75 | $3.41M | |
| Mark Sabag - Officer | Open-market sale | Ordinary Shares | 98,168 | $28.70 | $2.82M | |
| Mark Sabag - Officer | Option exercise | Stock Options (right to buy) | 118,724 | $0.00 | - | |
| Chen Lichtenstein | Option exercise | Ordinary Shares | 4,804 | - | - | |
| Chen Lichtenstein | Option exercise | Restricted Share Units | 4,804 | $0.00 | - | |
| Roberto Mignone | Open-market sale | Ordinary Shares | 50,000 | $26.03 | $1.30M | |
| Christine Fox - Officer | Option exercise | Ordinary Shares | 63,492 | - | - | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 28,229 | $24.78 | $700K | |
| Christine Fox - Officer | Option exercise | Restricted Share Units | 63,492 | $0.00 | - | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 30,000 | $25.11 | $753K | |
| Roberto Mignone | Open-market sale | Ordinary Shares | 200,000 | $24.11 | $4.82M | |
| Amir Weiss - Officer | Open-market sale | Ordinary Shares | 12,300 | $24.44 | $301K | |
| David R. McAvoy - Officer | Open-market purchase | Ordinary Shares | 1,113 | $18.86 | $21K | |
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 52,742 | - | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 52,742 | $15.16 | $799K | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 52,742 | $0.00 | - | |
| Placid Jover - Officer | Option exercise | Ordinary Shares | 12,827 | - | - | |
| Placid Jover - Officer | Open-market sale | Ordinary Shares | 6,053 | $15.16 | $92K | |
| Placid Jover - Officer | Option exercise | Restricted Share Units | 12,827 | $0.00 | - | |
| Roberto Mignone | Option exercise | Ordinary Shares | 9,632 | - | - | |
| Roberto Mignone | Option exercise | Restricted Share Units | 9,632 | $0.00 | - | |
| Roberto Mignone | Grant or award | Restricted Share Units | 14,492 | $0.00 | - | |
| Sol J. Barer | Option exercise | Ordinary Shares | 17,158 | - | - | |
| Sol J. Barer | Option exercise | Restricted Share Units | 17,158 | $0.00 | - | |
| Sol J. Barer | Grant or award | Restricted Share Units | 21,739 | $0.00 | - | |
| Gerald M. Lieberman | Option exercise | Ordinary Shares | 9,632 | - | - | |
| Gerald M. Lieberman | Option exercise | Restricted Share Units | 9,632 | $0.00 | - | |
| Gerald M. Lieberman | Grant or award | Restricted Share Units | 14,492 | $0.00 | - | |
| Roberto Mignone | Open-market sale | Ordinary Shares | 286,000 | $22.01 | $6.29M | |
| Chen Lichtenstein | Grant or award | Restricted Share Units | 4,804 | $0.00 | - | |
| Christine Fox - Officer | Option exercise | Ordinary Shares | 63,492 | - | - | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 19,388 | $16.87 | $327K | |
| Christine Fox - Officer | Option exercise | Restricted Share Units | 63,492 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 89 TEVA filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lippman Evan | Officer, EVP BUSINESS DEVELOPMENT | 18,600 | $680K | View on EDGAR | |
| Jover Placid | Executive VP, Chief HR Officer | 12,827 | $447K | View on EDGAR | |
| Hughes Eric A | Executive VP Global R&D and Chief Med Officer | 25,578 | $892K | View on EDGAR |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) had 19 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for TEVA runs to 89 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TEVA were filed in the last 90 days. 1 purchase is on record for this company.
11 insider sales of TEVA were filed in the last 90 days, totaling $7.09M.
This page tracks TEVA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TEVA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
